Sort   by:  
 Page size 
UnknownA randomized, phase II, biomarker-selected study comparing erlotinib to erlotinib intercalated with chemotherapy in first-line therapy for advanced non-small-cell lung cancer.
Not available
S-EPMC3179254 | biostudies-literature
UnknownRandomized phase II trial of erlotinib with and without entinostat in patients with advanced non-small-cell lung cancer who progressed on prior chemotherapy.
Not available
S-EPMC4798782 | biostudies-literature
UnknownPrognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOG.
Not available
S-EPMC3208275 | biostudies-literature
UnknownLung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400.
Not available
S-EPMC4654466 | biostudies-literature
UnknownSmall Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?
Not available
S-EPMC4836290 | biostudies-literature
Sort   by:  
 Page size